Doppler and AFV for Outcome Prediction ın FGR

The investigator contrived a prospective study of AUCR to compare its association to adverse perinatal outcomes with other established doppler parameters, such as CPR and UCR within a population of suspected FGR fetuses at term.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Fetal Growth Retardation Congenital, Hereditary, and Neonatal Diseases and Abnormalities Female Urogenital Diseases and Pregnancy Complications Fetal Diseases Growth Disorders Pathologic Processes Pathological Conditions, Signs and Symptoms Pregnancy Complications Urogenital Diseases

Age range

18 year–40 year

Sex eligibility

Female

Study type

Observational

Primary location

Ankara City Hospital

Ankara, 06810, Turkey (Türkiye)

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

SİNGLETON PREGNANCİES WİTH FGR FETUSES
AFTER 37th GESTATİONAL WEEKS

Exclusion criteria

SİNGLE OR MUTİPL FETAL ANOMALİES
EVİDENCE OF İNTRAUTERİNE ENFECTİON

Treatment and study plan

Doppler measurement in combination with amniotic fluid volume

Diagnostic Test

Ultrasonographic evaluation

Primary outcomes

the prediction power of adverse perinatal outcome with new doppler parameters ( such as AUCR)

Time frame: 1 year

enterence to neonatal intensive care unit and severe fetal acidemia ( pH: >7.10)

Sponsors and collaborators

Lead sponsor

Istanbul Bakirkoy Maternity and Children Diseases Hospital

Other Gov

Registry information

Official study title

Combination of Doppler Measurements With Amniotic Fluid Volume for the Predicition of Perinatal Outcome in FGR

Important dates

Study start: 2020
Primary completion: 2020
Study completion: 2020
First posted: Mar 25, 2022
Registry last updated: Mar 25, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed